Cargando…

Mitochondrial Mechanisms of LRRK2 G2019S Penetrance

Several mutations in leucine-rich repeat kinase-2 (LRRK2) have been associated with Parkinson's disease (PD). The most common substitution, G2019S, interferes with LRRK2 kinase activity, which is regulated by autophosphorylation. Yet, the penetrance of this gain-of-function mutation is incomple...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delcambre, Sylvie, Ghelfi, Jenny, Ouzren, Nassima, Grandmougin, Léa, Delbrouck, Catherine, Seibler, Philip, Wasner, Kobi, Aasly, Jan O., Klein, Christine, Trinh, Joanne, Pereira, Sandro L., Grünewald, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477385/ https://www.ncbi.nlm.nih.gov/pubmed/32982917 http://dx.doi.org/10.3389/fneur.2020.00881

Ejemplares similares

Mitochondrial DNA Deletions Discriminate Affected from Unaffected LRRK2 Mutation Carriers
por: Ouzren, Nassima, et al.
Publicado: (2019)

Nanopore Single-Molecule Sequencing for Mitochondrial DNA Methylation Analysis: Investigating Parkin-Associated Parkinsonism as a Proof of Concept
por: Lüth, Theresa, et al.
Publicado: (2021)

The Role of Rare Coding Variants in Parkinson's Disease GWAS Loci
por: Germer, Elisabeth Luisa, et al.
Publicado: (2019)

LIPAD (LRRK2/Luebeck International Parkinson's Disease) Study Protocol: Deep Phenotyping of an International Genetic Cohort
por: Usnich, Tatiana, et al.
Publicado: (2021)

Genome-wide case-only analysis of gene-gene interactions with known Parkinson’s disease risk variants reveals link between LRRK2 and SYT10
por: Aleknonytė-Resch, Milda, et al.
Publicado: (2023)

Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism
por: Borsche, Max, et al.
Publicado: (2020)

Sleep Spindles and Fragmented Sleep as Prodromal Markers in a Preclinical Model of LRRK2-G2019S Parkinson's Disease
por: Crown, Lindsey M., et al.
Publicado: (2020)

3D Cultures of Parkinson's Disease‐Specific Dopaminergic Neurons for High Content Phenotyping and Drug Testing
por: Bolognin, Silvia, et al.
Publicado: (2018)

Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1/PRKN-linked Parkinson’s disease
por: Trinh, Joanne, et al.
Publicado: (2022)

Elevated LRRK2 autophosphorylation in brain-derived and peripheral exosomes in LRRK2 mutation carriers
por: Wang, Shijie, et al.
Publicado: (2017)

Exploring cancer in LRRK2 mutation carriers and idiopathic Parkinson's disease
por: Warø, Bjørg Johanne, et al.
Publicado: (2017)

The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study
por: Latourelle, Jeanne C, et al.
Publicado: (2008)

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
por: Healy, Daniel G, et al.
Publicado: (2008)

Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease
por: Smith, Laura J., et al.
Publicado: (2022)

Inflammatory Diseases Among Norwegian LRRK2 Mutation Carriers. A 15-Years Follow-Up of a Cohort
por: Aasly, Jan O.
Publicado: (2021)

Clinical and Imaging Markers of Prodromal Parkinson's Disease
por: Hustad, Eldbjørg, et al.
Publicado: (2020)

Four-Year Longitudinal Study of Motor and Non-motor Symptoms in LRRK2-Related Parkinson's Disease
por: Deng, Xiao, et al.
Publicado: (2020)

Novel Variants in LRRK2 and GBA Identified in Latino Parkinson Disease Cohort Enriched for Caribbean Origin
por: Nuytemans, Karen, et al.
Publicado: (2020)

A More Homogeneous Phenotype in Parkinson's Disease Related to R1441G Mutation in the LRRK2 Gene
por: Vinagre-Aragón, Ana, et al.
Publicado: (2021)

Hypergravity exposure during gestation modifies the TCRβ repertoire of newborn mice
por: Ghislin, Stéphanie, et al.
Publicado: (2015)

What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson’s Disease Patients and Healthy Subjects with Parkinson’s-Associated LRRK2 Mutations?
por: Loeffler, David A., et al.
Publicado: (2019)

Metabolomic Profiling in LRRK2-Related Parkinson's Disease
por: Johansen, Krisztina K., et al.
Publicado: (2009)

LRRK2 in Parkinson's disease – drawing the curtain of penetrance: a commentary
por: Krüger, Rejko
Publicado: (2008)

Chronic Hypergravity Induces a Modification of Histone H3 Lysine 27 Trimethylation at TCRβ Locus in Murine Thymocytes
por: Calcagno, Gaetano, et al.
Publicado: (2022)

Development of mutation-selective LRRK2 kinase inhibitors as precision medicine for Parkinson's disease and other diseases for which carriers are at increased risk
por: Lesniak, Robert K., et al.
Publicado: (2022)

Comparison of two protocols for the generation of iPSC-derived human astrocytes
por: Mulica, Patrycja, et al.
Publicado: (2023)

Parkin Exon Rearrangements and Sequence Variants in LRRK2 Mutations Carriers: Analysis on a Possible Modifier Effect on LRRK2 Penetrance
por: Solla, Paolo, et al.
Publicado: (2010)

Effect of LRRK2 G2385R Variant on Subthalamic Deep Brain Stimulation Efficacy in Parkinson's Disease in a Han Chinese Population
por: Chen, Si, et al.
Publicado: (2019)

Differential LRRK2 signalling and gene expression in WT-LRRK2 and G2019S-LRRK2 mouse microglia treated with zymosan and MLi2
por: Nazish, Iqra, et al.
Publicado: (2023)

Dysregulated mRNA Translation in the G2019S LRRK2 and LRRK2 Knock-Out Mouse Brains
por: Kim, Jungwoo Wren, et al.
Publicado: (2021)

Frequency of Heterozygous Parkin (PRKN) Variants and Penetrance of Parkinson's Disease Risk Markers in the Population-Based CHRIS Cohort
por: Castelo Rueda, Maria Paulina, et al.
Publicado: (2021)

Differential Inhibition of LRRK2 in Parkinson's Disease Patient Blood by a G2019S Selective LRRK2 Inhibitor
por: Bright, Jessica M., et al.
Publicado: (2021)

Incidence, Demographics, and Outcomes of Penetrating Trauma in Sweden During the Past Decade
por: Günther, Mattias, et al.
Publicado: (2021)

Changes to Intermediary Metabolites in Sporadic and LRRK2 Parkinson's Disease Demonstrated by Proton Magnetic Resonance Spectroscopy
por: Aasly, Jan O., et al.
Publicado: (2015)

Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice
por: Beccano-Kelly, Dayne A., et al.
Publicado: (2014)

Expression Analysis of Lrrk1, Lrrk2 and Lrrk2 Splice Variants in Mice
por: Giesert, Florian, et al.
Publicado: (2013)

Enduring Neuroprotective Effect of Subacute Neural Stem Cell Transplantation After Penetrating TBI
por: Kassi, Anelia A. Y., et al.
Publicado: (2019)

Comprehensive Profile of Acute Mitochondrial Dysfunction in a Preclinical Model of Severe Penetrating TBI
por: Pandya, Jignesh D., et al.
Publicado: (2019)

Orbitocranial Penetrating Injury With Multiple Vessel Invasion in an Infant: A Case Report and Literature Review
por: Wu, Yun, et al.
Publicado: (2020)

Case Report: Management of Traumatic Carotid-Cavernous Fistulas in the Acute Setting of Penetrating Brain Injury
por: Loggini, Andrea, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1c8khoa096fdsqdn5749ig0hgl